-
1
-
-
50649104448
-
Headache: One of the most common and troublesome adverse reactions to drugs
-
Ferrari A (2006) Headache: One of the most common and troublesome adverse reactions to drugs. Curr Drug Saf 1:43-58
-
(2006)
Curr Drug Saf
, vol.1
, pp. 43-58
-
-
Ferrari, A.1
-
2
-
-
0014457089
-
International drug monitoring: The role of the hospital
-
World Health Organization
-
World Health Organization (1969) International drug monitoring: The role of the hospital. Tech Rep Ser 425:5-25
-
(1969)
Tech Rep Ser
, vol.425
, pp. 5-25
-
-
-
3
-
-
0008653157
-
Cancer treatment: WHO recommendations for grading of acute and subacute toxicity
-
World Health Organization
-
World Health Organization (1981) Cancer treatment: WHO recommendations for grading of acute and subacute toxicity. Cancer 47:207-214
-
(1981)
Cancer
, vol.47
, pp. 207-214
-
-
-
4
-
-
0027196529
-
MEDWatch: The new FDA medical products reporting program
-
Kessler DA (1993) MEDWatch: The new FDA medical products reporting program. Clin Pharm 12:529-532
-
(1993)
Clin Pharm
, vol.12
, pp. 529-532
-
-
Kessler, D.A.1
-
5
-
-
0036517353
-
Do standard doses of frequently prescribed drugs cause preventable adverse effects in women?
-
Cohen JS (2002) Do standard doses of frequently prescribed drugs cause preventable adverse effects in women? J Am Med Womens Assoc 57:105-110
-
(2002)
J Am Med Womens Assoc
, vol.57
, pp. 105-110
-
-
Cohen, J.S.1
-
6
-
-
0026440241
-
Idiosyncratic drug reactions: A mechanistic evaluation of risk factors
-
Park BK, Pirmohamed M, Kitteringham NR (1992) Idiosyncratic drug reactions: A mechanistic evaluation of risk factors. Br J Clin Pharmacol 34:377-395
-
(1992)
Br J Clin Pharmacol
, vol.34
, pp. 377-395
-
-
Park, B.K.1
Pirmohamed, M.2
Kitteringham, N.R.3
-
7
-
-
0035996570
-
Mechanism of idiosyncratic drug reactions: Reactive metabolite formation, protein binding and the regulation of the immune system
-
Ju C, Uetrecht JP (2002) Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system. Curr Drug Metab 3:367-377
-
(2002)
Curr Drug Metab
, vol.3
, pp. 367-377
-
-
Ju, C.1
Uetrecht, J.P.2
-
8
-
-
2442433545
-
Clarifying adverse drug events: A clinician's guide to terminology, documentation, and reporting
-
Nebeker JR, Barach P, Samore MH (2004) Clarifying adverse drug events: A clinician's guide to terminology, documentation, and reporting. Ann Intern Med 140:795-801
-
(2004)
Ann Intern Med
, vol.140
, pp. 795-801
-
-
Nebeker, J.R.1
Barach, P.2
Samore, M.H.3
-
9
-
-
33746861906
-
Pharmacovigilance during the pre-approval phases: An evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines
-
Hartford CG, Petchel KS, Mickail H et al (2006) Pharmacovigilance during the pre-approval phases: An evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines. Drug Saf 29:657-673
-
(2006)
Drug Saf
, vol.29
, pp. 657-673
-
-
Hartford, C.G.1
Petchel, K.S.2
Mickail, H.3
-
10
-
-
0032903316
-
Problems assessing non-serious adverse drug reactions: Antidepressant drug therapy and sexual dysfunction
-
Michels KB (1999) Problems assessing non-serious adverse drug reactions: antidepressant drug therapy and sexual dysfunction. Pharmacotherapy 19:424-429
-
(1999)
Pharmacotherapy
, vol.19
, pp. 424-429
-
-
Michels, K.B.1
-
11
-
-
0035651985
-
Prescription-event monitoring and reporting of adverse drug reactions
-
Heeley E, Riley J, Layton D et al (2001) Prescription-event monitoring and reporting of adverse drug reactions. Lancet 358:1872-1873
-
(2001)
Lancet
, vol.358
, pp. 1872-1873
-
-
Heeley, E.1
Riley, J.2
Layton, D.3
-
12
-
-
0036195685
-
Improving safety reporting from randomised trials
-
Ioannidis JPA, Lau J (2002) Improving safety reporting from randomised trials. Drug Saf 25:77-84
-
(2002)
Drug Saf
, vol.25
, pp. 77-84
-
-
Ioannidis, J.P.A.1
Lau, J.2
-
13
-
-
0035946763
-
Safety reporting in clinical trials
-
Neidig JL, Koletar SL (2001) Safety reporting in clinical trials. J Am Med Assoc 285:2077-2078
-
(2001)
J Am Med Assoc
, vol.285
, pp. 2077-2078
-
-
Neidig, J.L.1
Koletar, S.L.2
-
14
-
-
0034649061
-
Epidemiological assessment of drug-induced disease
-
Kaufman DW, Shapiro S (2002) Epidemiological assessment of drug-induced disease. Lancet 356:1339-1343
-
(2002)
Lancet
, vol.356
, pp. 1339-1343
-
-
Kaufman, D.W.1
Shapiro, S.2
-
15
-
-
33646744337
-
Under-reporting of adverse drug reactions: A systematic review
-
Hazell L, Shakir SA (2006) Under-reporting of adverse drug reactions: A systematic review. Drug Saf 29:385-396
-
(2006)
Drug Saf
, vol.29
, pp. 385-396
-
-
Hazell, L.1
Shakir, S.A.2
-
16
-
-
0030111227
-
Methods for monitoring and documenting adverse drug reactions
-
Venulet J, ten Ham M (1996) Methods for monitoring and documenting adverse drug reactions. Int J Clin Pharmacol Ther 34:112-129
-
(1996)
Int J Clin Pharmacol Ther
, vol.34
, pp. 112-129
-
-
Venulet, J.1
ten Ham, M.2
-
17
-
-
33646057869
-
-
Headache Classification Subcommittee of the International Headache Society 2nd edn. Cephalalgia
-
Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders, 2nd edn. Cephalalgia 24(Suppl 1):1-160
-
(2004)
The International Classification of Headache Disorders
, vol.24
, Issue.SUPPL. 1
, pp. 1-160
-
-
-
18
-
-
31344471005
-
Medication-attributed adverse effects in placebo groups: Implications for assessment of adverse effects
-
Rief W, Avorn J, Barsky AJ (2006) Medication-attributed adverse effects in placebo groups: Implications for assessment of adverse effects. Arch Intern Med 166:155-160
-
(2006)
Arch Intern Med
, vol.166
, pp. 155-160
-
-
Rief, W.1
Avorn, J.2
Barsky, A.J.3
-
19
-
-
58849162823
-
The burden of migraine in the United States: Current and emerging perspectives on disease management and economic analysis
-
Hazard E, Munakata J, Bigal ME et al (2009) The burden of migraine in the United States: Current and emerging perspectives on disease management and economic analysis. Value Health 12:55-64
-
(2009)
Value Health
, vol.12
, pp. 55-64
-
-
Hazard, E.1
Munakata, J.2
Bigal, M.E.3
-
20
-
-
43749091268
-
Adverse drug reaction reporting by patients in the Netherlands: Three years of experience
-
De Langen J, van Hunsel F, Passier A et al (2008) Adverse drug reaction reporting by patients in the Netherlands: Three years of experience. Drug Saf 31:515-524
-
(2008)
Drug Saf
, vol.31
, pp. 515-524
-
-
De Langen, J.1
van Hunsel, F.2
Passier, A.3
-
21
-
-
56349153303
-
Net efficacy adjusted for risk (NEAR): A simple procedure for measuring risk: Benefit balance
-
doi: 10.1371/journal.pone.0003580
-
Boada JN, Boada C, García-Sáiz M et al (2008) Net efficacy adjusted for risk (NEAR): A simplB procedure for measuring risk: benefit balance. PLoS ONE. doi: 10.1371/journal.pone.0003580
-
(2008)
PLoS ONE
-
-
Boada, J.N.1
Boada, C.2
García-Sáiz, M.3
-
22
-
-
0032856372
-
Adverse drug reactions and polypharmacy in the elderly in general practice
-
Veehof LJ, Stewart RE, Meyboom-de Jong B et al (1999) Adverse drug reactions and polypharmacy in the elderly in general practice. Eur J Clin Pharmacol 55:533-536
-
(1999)
Eur J Clin Pharmacol
, vol.55
, pp. 533-536
-
-
Veehof, L.J.1
Stewart, R.E.2
Meyboom-de Jong, B.3
-
23
-
-
40749114043
-
Epidemiology and comorbidity of headache
-
Jensen R, Stovner LJ (2008) Epidemiology and comorbidity of headache. Lancet Neurol 7:354-361
-
(2008)
Lancet Neurol
, vol.7
, pp. 354-361
-
-
Jensen, R.1
Stovner, L.J.2
-
24
-
-
53249086098
-
Women encounter ADRs more often than do men
-
Zopf Y, Rabe C, Neubert A et al (2008) Women encounter ADRs more often than do men. Eur J Clin Pharmacol 64:999-1004
-
(2008)
Eur J Clin Pharmacol
, vol.64
, pp. 999-1004
-
-
Zopf, Y.1
Rabe, C.2
Neubert, A.3
-
25
-
-
33846243801
-
Similarities and differences between chronic migraine and episodic migraine
-
Ferrari A, Leone S, Vergoni AV et al (2007) Similarities and differences between chronic migraine and episodic migraine. Headache 47:65-72
-
(2007)
Headache
, vol.47
, pp. 65-72
-
-
Ferrari, A.1
Leone, S.2
Vergoni, A.V.3
-
26
-
-
43749087335
-
Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: A prospective study of 1756 patients
-
Franceschi M, Scarcelli C, Niro V et al (2008) Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: A prospective study of 1756 patients. Drug Saf 31:545-556
-
(2008)
Drug Saf
, vol.31
, pp. 545-556
-
-
Franceschi, M.1
Scarcelli, C.2
Niro, V.3
-
27
-
-
0034619028
-
Adverse drug reactions: Definitions, diagnosis, and management
-
Edwards IR, Aronson JK (2000) Adverse drug reactions: Definitions, diagnosis, and management. Lancet 356:1255-1259
-
(2000)
Lancet
, vol.356
, pp. 1255-1259
-
-
Edwards, I.R.1
Aronson, J.K.2
-
29
-
-
0028043398
-
Nitroglycerin-induced headache is not dependent on histamine release: Support for a direct nociceptive action of nitric oxide
-
Iversen HK, Olesen J (1994) Nitroglycerin-induced headache is not dependent on histamine release: Support for a direct nociceptive action of nitric oxide. Cephalalgia 14:437-442
-
(1994)
Cephalalgia
, vol.14
, pp. 437-442
-
-
Iversen, H.K.1
Olesen, J.2
-
30
-
-
0034919999
-
Drug-related adverse events: A readers' guide to assessing literature reviews and meta-analyses
-
Ross SD (2001) Drug-related adverse events: A readers' guide to assessing literature reviews and meta-analyses. Arch Intern Med 161:1041-1046
-
(2001)
Arch Intern Med
, vol.161
, pp. 1041-1046
-
-
Ross, S.D.1
-
32
-
-
33746101875
-
Dipyridamole may induce migraine in patients with migraine without aura
-
Kruuse C, Lassen LH, Iversen HK et al (2006) Dipyridamole may induce migraine in patients with migraine without aura. Cephalalgia 26:925-933
-
(2006)
Cephalalgia
, vol.26
, pp. 925-933
-
-
Kruuse, C.1
Lassen, L.H.2
Iversen, H.K.3
-
33
-
-
0028118203
-
A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks
-
Thomsen LL, Kruuse C, Iversen HK et al (1994) A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur J Neurol 1:73-80
-
(1994)
Eur J Neurol
, vol.1
, pp. 73-80
-
-
Thomsen, L.L.1
Kruuse, C.2
Iversen, H.K.3
-
34
-
-
5444243613
-
Phosphodiesterase-5 inhibitors and migraine
-
Evans RW, Kruuse C (2004) Phosphodiesterase-5 inhibitors and migraine. Headache 44:925-926
-
(2004)
Headache
, vol.44
, pp. 925-926
-
-
Evans, R.W.1
Kruuse, C.2
-
35
-
-
22644446283
-
Migraines linked to interferon-beta treatment of multiple sclerosis
-
Khromov A, Segal M, Nissinoff J et al (2005) Migraines linked to interferon-beta treatment of multiple sclerosis. Am J Phys Med Rehabil 84:644-647
-
(2005)
Am J Phys Med Rehabil
, vol.84
, pp. 644-647
-
-
Khromov, A.1
Segal, M.2
Nissinoff, J.3
-
36
-
-
0036880354
-
Migraine-type headaches in children receiving chemotherapy and ondansetron
-
Khan RB (2002) Migraine-type headaches in children receiving chemotherapy and ondansetron. J Child Neurol 17:857-858
-
(2002)
J Child Neurol
, vol.17
, pp. 857-858
-
-
Khan, R.B.1
-
37
-
-
15344339211
-
Calcineurin inhibitor-induced headache: Clinical characteristics and possible mechanisms
-
Ferrari U, Empl M, Kim KS et al (2005) Calcineurin inhibitor-induced headache: Clinical characteristics and possible mechanisms. Headache 45:211-214
-
(2005)
Headache
, vol.45
, pp. 211-214
-
-
Ferrari, U.1
Empl, M.2
Kim, K.S.3
-
39
-
-
0035121924
-
Migraine with aura after administration of sublingual nitroglycerin tablets
-
Bank J (2001) Migraine with aura after administration of sublingual nitroglycerin tablets. Headache 41:84-87
-
(2001)
Headache
, vol.41
, pp. 84-87
-
-
Bank, J.1
-
40
-
-
15344350140
-
Recurrence of migraine with aura due to tacrolimus therapy in a liver transplant recipient successfully treated with sirolimus substitution
-
Toth CC, Burak K, Becker W (2005) Recurrence of migraine with aura due to tacrolimus therapy in a liver transplant recipient successfully treated with sirolimus substitution. Headache 45:245-246
-
(2005)
Headache
, vol.45
, pp. 245-246
-
-
Toth, C.C.1
Burak, K.2
Becker, W.3
-
41
-
-
0027265271
-
Migraine with typical aura associated with fluoxetine therapy: Case report
-
Larson EW (1993) Migraine with typical aura associated with fluoxetine therapy: Case report. J Clin Psychiatry 54:235-236
-
(1993)
J Clin Psychiatry
, vol.54
, pp. 235-236
-
-
Larson, E.W.1
-
42
-
-
33750379444
-
Tadalafil associated with typical migraine aura without headache
-
Dinn RB, Wall M (2006) Tadalafil associated with typical migraine aura without headache. Cephalalgia 26:1344-1346
-
(2006)
Cephalalgia
, vol.26
, pp. 1344-1346
-
-
Dinn, R.B.1
Wall, M.2
-
43
-
-
0014360365
-
Nitrolglycerin as a provocative agent in cluster headache
-
Ekbom K (1968) Nitrolglycerin as a provocative agent in cluster headache. Arch Neurol 19:487-493
-
(1968)
Arch Neurol
, vol.19
, pp. 487-493
-
-
Ekbom, K.1
-
44
-
-
33645099900
-
Sildenafil can trigger cluster headaches
-
Evans RW (2006) Sildenafil can trigger cluster headaches. Headache 46:173-174
-
(2006)
Headache
, vol.46
, pp. 173-174
-
-
Evans, R.W.1
|